Not on air · 2 of 3 networks checked
Novo Nordisk Pharmatech A/S
- novonordiskpharmatech.com
- DK
- 553 employees
Novo Nordisk Pharmatech A/S’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 134. Watch Novo Nordisk Pharmatech A/S with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| None recorded | 0 | Checked 29 Oct 2026 | See all 134 ads → | ||
| Meta | Not checked | — | |||
| Recently | 200+ | Ads on the Google Ads Transparency Center | Checked 6 Oct 2026 | Collect them with the API → |
Novo Nordisk Pharmatech A/S has no live LinkedIn ads. We recorded 200+ Google ads on 6 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 26 Oct 2026
Fixed proprietary blends limit what process developers can adjust. TrypsiNNex® and Recombinant Insulin are individual, defined raw materials you can swap, tune and combine by cell line, virus and process stage. See how they perform together in Vero cells: https://lnkd.in/eTrRicDd
- LINKEDIN · IMAGESince 26 Oct 2026
Porcine trypsin brings adventitious agent risk into your upstream workflow. TrypsiNNex® is a recombinant, porcine-sequence trypsin built to replace it. Without the presence of EDTA, TrypsiNNex® dissociated adherent Vero cells with performance comparable to 0.25% Trypsin-EDTA. Download the application note: https://lnkd.in/emXUMFDJ
- LINKEDIN · IMAGESince 26 Oct 2026
Complete animal-free cell detachment between 5-10 minutes. Viability and density comparable to Trypsin-EDTA. TryspiNNex is the ideal porcine-genome recombinant reagent for Vero cells. Read the data in our new application note: https://lnkd.in/emXUMFDJ
- LINKEDIN · IMAGESince 26 Oct 2026
Animal-Free TrypsiNNex® kept Vero cell viability at approximately 95%, comparable to 0.25% Trypsin-EDTA, with viable cell density preserved. See the full dissociation data in our new application note: https://lnkd.in/emXUMFDJ
- LINKEDIN · IMAGESince 26 Oct 2026
For the first time, we tested TrypsiNNex® and Recombinant Insulin together in Vero cells, from dissociation and expansion through to HSV-1 propagation. The result is a workflow built on characterised, recombinant alternatives to animal-derived components. Download the new application note: https://lnkd.in/eTrRicDd
- LINKEDIN · IMAGESince 26 Oct 2026
Every animal-derived raw material adds to your qualification and traceability burden. TrypsiNNex® is a recombinant trypsin produced to cGMP standards and supplied with full documentation and regulatory support. Now tested in Vero cells, with efficient dissociation and high cell viability and density. Download the application note: https://lnkd.in/emXUMFDJ
6 of 134 adsSign up to see every Novo Nordisk Pharmatech A/S ad, filter by format and date, and get alerts on new ones.
See all 134 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.